Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Opdivo
Opdivo
ESMO: Facing new Keytruda combos from Merck, BMS touts 5-year kidney cancer data for Opdivo-Yervoy
Fierce Pharma
Thu, 09/16/21 - 10:56 am
Bristol Myers Squibb
Opdivo
Yervoy
kidney cancer
ESMO
Bristol Myers rolls out 3-year data mesothelioma data for Opdivo/Yervoy in first look at ESMO slate
Endpoints
Mon, 09/13/21 - 10:32 am
Bristol Myers Squibb
Opdivo
Yervoy
mesothelioma
FDA Approvals Roundup: Korsuva, Jardiance, Xarelto
RAPS.org
Fri, 08/27/21 - 10:36 am
Cara Therapeutics
Korsuva
Boehringer Ingelheim
Jardiance
Bristol Myers Squibb
Opdivo
FDA Action Alert: Cara/Vifor, Kadmon, BMS, Merck/Eisai
BioSpace
Mon, 08/23/21 - 11:10 am
FDA
Cara Therapeutics
Vifor Pharma
Korsuva
Kadmon
belumosudil
Bristol Myers Squibb
Opdivo
Merck
Eisai
Keytruda
Bristol Myers pulls lymphoma indication for Istodax after confirmatory trial falls flat
Endpoints
Mon, 08/2/21 - 10:07 pm
Bristol Myers Squibb
Istodax
Opdivo
Bristol Myers Squibb catches the SHP2 wave in a new collaboration deal with BridgeBio
Endpoints
Tue, 07/27/21 - 10:40 am
Bristol Myers Squibb
SHP2 inhibitors
Opdivo
BridgeBio
cancer
Another one bites the dust: Bristol Myers Squibb pulls 'dangling' accelerated approval for Opdivo in liver cancer
Endpoints
Mon, 07/26/21 - 09:45 am
Bristol Myers Squibb
Opdivo
FDA
liver cancer
Bristol Myers Squibb takes another late-stage loss for Opdivo-Yervoy combo in head and neck cancer
Endpoints
Fri, 07/16/21 - 10:55 am
Bristol Myers Squibb
Opdivo
head and neck cancer
clinical trials
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
Mon, 07/12/21 - 11:08 am
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
BMS Flying High in May With Opdivo, Zeposia FDA Approvals
BioSpace
Fri, 05/28/21 - 11:23 am
Bristol Myers Squibb
FDA
clinical trials
Opdivo
Zeposia
ozanimod
ulcerative colitis
Bristol Myers' Opdivo leads the pack with FDA approval for resected esophageal or GEJ cancer
Endpoints
Fri, 05/21/21 - 11:48 am
Bristol Myers Squibb
Opdivo
FDA
esophageal cancer
gastroesophageal cancer
Bristol Myers details data for closely watched cancer immunotherapy
BioPharma Dive
Wed, 05/19/21 - 11:27 pm
ASCO 2021
immunotherapy
Bristol Myers Squibb
Opdivo
skin cancer
relatlimab
Clovis spikes ovarian cancer combo after 'underwhelming' efficacy; Servier wins priority review for Tibsovo expansion
Endpoints
Wed, 05/5/21 - 10:42 am
Clovis Oncology
earnings
Lucitanib
Opdivo
Bristol Myers Squibb
ovarian cancer
Merck, Roche and Bristol Myers nab 4 of 6 positive ODAC votes for ‘dangling’ accelerated approvals
Endpoints
Thu, 04/29/21 - 10:55 pm
Merck
Roche
Bristol Myers Squibb
FDA
ODAC
accelerated approvals
Keytruda
Opdivo
Tecentriq
What are Merck, Bristol Myers and Roche planning for the big FDA cancer approval review?
Fierce Pharma
Tue, 04/27/21 - 11:04 am
FDA
oncology
accelerated approvals
Merck
Keytruda
Bristol Myers Squibb
Opdivo
Roche
Tecentriq
FDA Advisory Committee to Review Checkpoint Inhibitors Greenlit Under Accelerated Approval
BioSpace
Sun, 04/25/21 - 01:56 pm
FDA
oncology
cancer
accelerated approvals
Bristol Myers Squibb
Opdivo
Roche
Tecentriq
Merck
Keytruda
Bristol Myers’ Opdivo Receives FDA Approval for Gastric Cancer
BioSpace
Mon, 04/19/21 - 10:32 pm
Bristol Myers Squibb
FDA
gastric cancer
Opdivo
Bristol Myers' Opdivo notches a double win against chemo in esophageal cancer, potentially setting up 1st-line nod
Endpoints
Thu, 04/8/21 - 11:12 am
Bristol Myers Squibb
Opdivo
clinical trials
esophageal cancer
Could Opdivo be a New Standard in Esophageal Cancer Therapy?
BioSpace
Fri, 04/2/21 - 10:50 am
Bristol Myers Squibb
Opdivo
esophageal cancer
Immuno-Oncology Treatments Finding Success with Combination Therapies
BioSpace
Thu, 03/25/21 - 11:44 am
immuno-oncology
Opdivo
Bristol-Myers Squibb
clinical trials
relatilimab
Ibrance
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »